TITLE

Acquisition of Invasion-Inhibitory Antibodies Specific for the 19-kDa Fragment of Merozoite Surface Protein 1 in a Transmigrant Population Requires Multiple Infections

AUTHOR(S)
Murhandarwati, E. Elsa Herdiana; Black, Casilda G.; Wang, Lina; Weisman, Simon; de Koning-Ward, Tania F.; Baird, J. Kevin; Tjitra, Emiliana; Richie, Thomas L.; Crabb, Brendan S.; Coppel, Ross L.
PUB. DATE
October 2008
SOURCE
Journal of Infectious Diseases;10/15/2008, Vol. 198 Issue 8, p1212
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Antibodies against the 19 kDa C-terminal fragment of merozoite surface protein 1 (MSP119) are a major component of the invasion-inhibitory response in individuals immune to malaria. We report here the acquisition of MSP119-specific invasion-inhibitory antibodies in a group of transmigrants who experienced their sequential malaria infections during settlement in an area of Indonesia where malaria is highly endemic. We used 2 transgenic Plasmodium falciparum parasite lines that expressed either endogenous MSP119 or the homologous region from P. chabaudi to measure the MSP119-specific invasion-inhibitory antibodies. The results revealed that the acquisition of MSP119-specific invasion-inhibitory antibodies required 2 or more P. falciparum infections. In contrast, enzyme-linked immunosorbent assays on the same serum samples showed that MSP119-specific antibodies are present after the first malaria infection. This delay in the acquisition of functional antibodies by residents of areas where malaria is endemic is consistent with the observation that multiple malaria infections are required before clinical immunity is acquired.
ACCESSION #
34779963

 

Related Articles

  • Potential impact of host immunity on malaria treatment outcome in Tanzanian children infected with Plasmodium falciparum. Enevold, Anders; Nkya, Watoky M. M. M.; Theisen, Michael; Vestergaard, Lasse S.; Jensen, Anja T. R.; Staalsoe, Trine; Theander, Thor G.; Bygbjerg, Ib C.; Alifrangis, Michael // Malaria Journal;2007, Vol. 6, p153 

    Background: In malaria endemic areas children may recover from malaria after chemotherapy in spite of harbouring genotypically drug-resistant Plasmodium falciparum. This phenomenon suggests that there is a synergy between drug treatment and acquired immunity. This hypothesis was examined in an...

  • Acquisition of Growth-Inhibitory Antibodies against Blood-Stage Plasmodium falciparum. McCallum, Fiona J.; Persson, Kristina E. M.; Mugyenyi, Cleopatra K.; Fowkes, Freya J. I.; Simpson, Julie A.; Richards, Jack S.; Williams, Thomas N.; Marsh, Kevin; Beeson, James G. // PLoS ONE;2008, Vol. 3 Issue 10, p1 

    Background: Antibodies that inhibit the growth of blood-stage Plasmodium falciparum may play an important role in acquired and vaccine-induced immunity in humans. However, the acquisition and activity of these antibodies is not well understood. Methods: We tested dialysed serum and purified...

  • How Should Antibodies against P. falciparum Merozoite Antigens Be Measured? Chuangchaiya, Sriwipa; Persson, Kristina E. M. // Journal of Tropical Medicine (16879686);2013, p1 

    Immunity against malaria develops slowly and only after repeated exposure to the parasite. Many of those that die of the disease are children under five years of age. Antibodies are an important part of immunity, but which antibodies that are protective and how these should be measured are still...

  • Humoral Immune Response to Mixed PfAMA1 Alleles; Multivalent PfAMA1 Vaccines Induce Broad Specificity. Kusi, Kwadwo A.; Faber, Bart W.; Thomas, Alan W.; Remarque, Edmond J. // PLoS ONE;2009, Vol. 4 Issue 12, p1 

    Apical Membrane Antigen 1 (AMA1), a merozoite protein essential for red cell invasion, is a candidate malaria vaccine component. Immune responses to AMA1 can protect in experimental animal models and antibodies isolated from AMA1- vaccinated or malaria-exposed humans can inhibit parasite...

  • Standardization and validation of a cytometric bead assay to assess antibodies to multiple Plasmodium falciparum recombinant antigens. Ondigo, Bartholomew N.; Park, Gregory S.; Gose, Severin O.; Ho, Benjamin M.; Ochola, Lyticia A.; Ayodo, George O.; Ofulla, Ayub V.; John, Chandy C. // Malaria Journal;2012, Vol. 11 Issue 1, p427 

    Background: Multiplex cytometric bead assay (CBA) have a number of advantages over ELISA for antibody testing, but little information is available on standardization and validation of antibody CBA to multiple Plasmodium falciparum antigens. The present study was set to determine optimal...

  • Validation of oral fluid samples to monitor serological changes to Plasmodium falciparum: An observational study in southern Zambia.  // Malaria Journal;2011, Vol. 10 Issue 1, p162 

    The article presents a research on validating use of oral fluid (OF) or saliva samples to measure serological changes to Plasmodium falciparum antigens. In this study, an enzyme immunoassay was developed to detect antibodies to asexual stage P. falciparum antigens, and the results from DBS and...

  • Phase 1 Trial of AMA1-C1/Alhydrogel plus CPG 7909: An Asexual Blood-Stage Vaccine for Plasmodium falciparum Malaria. Mullen, Gregory E. D.; Ellis, Ruth D.; Miura, Kazutoyo; Malkin, Elissa; Nolan, Caroline; Hay, Mhorag; Fay, Michael P.; Saul, Allan; Zhu, Daming; Rausch, Kelly; Moretz, Samuel; Hong Zhou; Long, Carole A.; Miller, Louis H.; Treanor, John // PLoS Clinical Trials;Aug2008, Vol. 5 Issue 8, Special section p1 

    Background: Apical Membrane Antigen 1 (AMA1), a polymorphic merozoite surface protein, is a leading blood-stage malaria vaccine candidate. This is the first reported use in humans of an investigational vaccine, AMA1-C1/Alhydrogel, with the novel adjuvant CPG 7909. Methods:A phase 1 trial was...

  • Antigenicity of Synthetic Peptides Derived from Plasmodium Apoptosis-Linked Pathogenicity Factors. Bisvigou, Ulrick; Zang-Edou, Estelle Sonya; Noulin, Florian; Zatra, Rafika; Mevono, Ludovic; L�kana-Douki, Jean-Bernard; Mazier, Dominique; Gay, Fr�d�rick; Ndouo, Fousseyni S. Tour� // Journal of Life Sciences;Jun2012, Vol. 6 Issue 6, p587 

    Background: Plasmodium falciparum malaria remains a major life-threatening disease. Recently, the Plasmodium apoptosis-linked pathogenicity factors (PALPF) have been identified. These antigens PALPF are expressed only by P. falciparum-infected erythrocytes triggering endothelial cell apoptosis...

  • A new ELISA kit which uses a combination of Plasmodium falciparum extract and recombinant Plasmodium vivax antigens as an alternative to IFAT for detection of malaria antibodies. Doderer, Cecile; Heschung, Aurelie; Guntz, Phillippe; Cazenave, Jean-Pierre; Hansmann, Yves; Senegas, Alexandre; Pfaff, Alexander W.; Abdelrahman, Tamer; Candolfi, Ermanno // Malaria Journal;2007, Vol. 6, p1 

    Background: The methods most commonly used to measure malarial antibody titres are the Indirect Fluorescence Antibody Test (IFAT), regarded as the gold standard, and the Enzyme-Linked ImmunoSorbent Assay (ELISA). The objective here was to assess the diagnostic performance, i.e. the sensitivity...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics